BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9665480)

  • 1. Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.
    Tanner MM; Karhu RA; Nupponen NN; Borg A; Baldetorp B; Pejovic T; Fernö M; Killander D; Isola JJ
    Am J Pathol; 1998 Jul; 153(1):191-9. PubMed ID: 9665480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer.
    Rennstam K; Baldetorp B; Kytölä S; Tanner M; Isola J
    Cancer Res; 2001 Feb; 61(3):1214-9. PubMed ID: 11221853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetics of primary breast cancer by CGH.
    Tirkkonen M; Tanner M; Karhu R; Kallioniemi A; Isola J; Kallioniemi OP
    Genes Chromosomes Cancer; 1998 Mar; 21(3):177-84. PubMed ID: 9523192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors.
    Hermsen MA; Baak JP; Meijer GA; Weiss JM; Walboomers JW; Snijders PJ; van Diest PJ
    J Pathol; 1998 Dec; 186(4):356-62. PubMed ID: 10209483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal imbalances in laryngeal and hypopharyngeal cancers detected by comparative genomic hybridization.
    Juhász A; Balázs M; Sziklay I; Rákosy Z; Treszl A; Répássy G; Adány R
    Cytometry A; 2005 Oct; 67(2):151-60. PubMed ID: 16163698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations in ERBB2-amplified breast carcinomas.
    Isola J; Chu L; DeVries S; Matsumura K; Chew K; Ljung BM; Waldman FM
    Clin Cancer Res; 1999 Dec; 5(12):4140-5. PubMed ID: 10632352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisation.
    Pinto AE; Roque L; Rodrigues R; André S; Soares J
    J Clin Pathol; 2006 Apr; 59(4):367-72. PubMed ID: 16461572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
    J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
    De Angelis PM; Clausen OP; Schjølberg A; Stokke T
    Br J Cancer; 1999 May; 80(3-4):526-35. PubMed ID: 10408863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
    Courjal F; Theillet C
    Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas.
    Speicher MR; Howe C; Crotty P; du Manoir S; Costa J; Ward DC
    Cancer Res; 1995 Mar; 55(5):1010-3. PubMed ID: 7866983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers.
    Mangia A; Chiarappa P; Tommasi S; Chiriatti A; Petroni S; Schittulli F; Paradiso A
    Cancer Genet Cytogenet; 2008 Apr; 182(2):75-83. PubMed ID: 18406868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
    Rennstam K; Ahlstedt-Soini M; Baldetorp B; Bendahl PO; Borg A; Karhu R; Tanner M; Tirkkonen M; Isola J
    Cancer Res; 2003 Dec; 63(24):8861-8. PubMed ID: 14695203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
    Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H
    Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
    Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.